Foxo Technologies Inc - SIC # 7374 - COMPUTER PROCESSING AND DATA PREPARATION AND PROCESSING SERVICES

Ticker Exchange SIC # Website Latest Ticker
FOXO American 7374 http://delwinds.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Foxo Technologies Inc

FOXO Technologies On Track to Commence Commercial Rollout of VITHAR™ AI Health Coach in Early 2024 - Dec 1st, 2023 2:01 pm
FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q - Nov 29th, 2023 9:30 pm
FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health Coach - Nov 10th, 2023 1:30 pm
FOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time - Nov 8th, 2023 2:00 pm
FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split - Nov 7th, 2023 2:23 pm
FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Company’s Epigenetic Data with the Power of AI - Oct 30th, 2023 12:30 pm
FOXO Technologies Inc. Announces Reverse Stock Split - Oct 27th, 2023 9:15 pm
FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy - Oct 23rd, 2023 12:00 pm
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers - Oct 13th, 2023 12:00 pm
FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions - Oct 6th, 2023 12:30 pm
FOXO Technologies Announces Agreement With Atrio Insurance - Sep 6th, 2023 12:30 pm
FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan - Aug 31st, 2023 12:30 pm
FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American - Aug 18th, 2023 8:15 pm
FOXO Technologies™ Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity - Aug 17th, 2023 12:30 pm
FOXO Technologies™ Announces Second Quarter 2023 Financial Results - Aug 10th, 2023 8:05 pm
FOXO Technologies™ Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT - Aug 8th, 2023 12:30 pm
Longevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories - Aug 7th, 2023 12:30 pm
FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis - Jul 19th, 2023 12:00 pm
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements - Jun 16th, 2023 9:30 am
FOXO Technologies Announces Results of Annual Stockholders Meeting - May 30th, 2023 9:09 pm